Research location
Huddersfield
United Kingdom
Advertisement
Research activity in Huddersfield
United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 47 trials and 47 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Huddersfield
47 linked trials · page 1 of 1A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)NCT07174336 · 2025-12-22 · 1 site observation
RECRUITING
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic AlterationsNCT07291037 · 2025-10-31 · 1 site observation
RECRUITING
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung CancerNCT06890598 · 2025-03-27 · 1 site observation
RECRUITING
Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised TrialNCT06309238 · 2024-05-08 · 1 site observation
RECRUITING
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerNCT06119581 · 2023-12-21 · 1 site observation
RECRUITING
A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)NCT05085028 · 2022-06-23 · 1 site observation
RECRUITING
Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis StudyNCT05432739 · 2021-04-07 · 1 site observation
RECRUITING
Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant ChemotherapyNCT04109079 · 2021-02-26 · 1 site observation
RECRUITING
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis StudyNCT04204915 · 2020-03-10 · 1 site observation
RECRUITING
Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With ChemotherapyNCT06449209 · 2024-08-05 · 1 site observation
ACTIVE_NOT_RECRUITING
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast CancerNCT05592483 · 2023-07-07 · 1 site observation
TERMINATED
PreOperative Endocrine Therapy for Individualised Care With AbemaciclibNCT04584853 · 2020-12-23 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)NCT04513925 · 2020-08-24 · 1 site observation
COMPLETED
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical PracticeNCT03782207 · 2019-02-07 · 1 site observation
COMPLETED
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast CancerNCT03498716 · 2018-08-02 · 1 site observation
TERMINATED
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday LifeNCT03000192 · 2016-08-01 · 1 site observation
UNKNOWN
Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former SmokersNCT02264990 · 2014-09-30 · 1 site observation
COMPLETED
AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT02151981 · 2014-08-04 · 1 site observation
COMPLETED
Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast CancerNCT01992952 · 2014-05-07 · 1 site observation
ACTIVE_NOT_RECRUITING
A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast CancerNCT02216786 · 2014-01-16 · 1 site observation
COMPLETED
Parp Inhibitor in Advanced Non-Small Cell Lung Cancer (PIN)NCT01788332 · 2014-01-01 · 1 site observation
UNKNOWN
A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical CareNCT02236637 · 2013-06-14 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)NCT01772472 · 2013-04-03 · 1 site observation
COMPLETED
A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic SettingNCT01808573 · 2013-03-29 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based TreatmentNCT01702571 · 2012-11-27 · 1 site observation
COMPLETED
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerNCT01566721 · 2012-05-17 · 1 site observation
COMPLETED
European Study of Cardiovascular RiskNCT00882336 · 2009-05-01 · 1 site observation
COMPLETED
Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast CancerNCT00820222 · 2009-04-14 · 1 site observation
COMPLETED
Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast CancerNCT00667251 · 2008-10-07 · 1 site observation
COMPLETED
Trial of Perioperative Endocrine Therapy - Individualising CareNCT02338310 · 2008-09-01 · 1 site observation
ACTIVE_NOT_RECRUITING
An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.NCT00750880 · 2008-09-01 · 1 site observation
COMPLETED
Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast CancerNCT00703326 · 2008-08-06 · 1 site observation
COMPLETED
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate CancerNCT00626548 · 2008-01-01 · 1 site observation
TERMINATED
BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast CancerNCT00528567 · 2007-12-01 · 1 site observation
COMPLETED
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With HerceptinNCT01152606 · 2007-08-30 · 1 site observation
COMPLETED
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNCT00490139 · 2007-05-16 · 1 site observation
COMPLETED
Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid ArthritisNCT00420927 · 2006-12-01 · 1 site observation
COMPLETED
Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114NCT00296257 · 2006-02-01 · 1 site observation
TERMINATED
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)NCT00262067 · 2005-12-01 · 1 site observation
UNKNOWN
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast CancerNCT00320385 · 2005-11-01 · 1 site observation
COMPLETED
A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast CancerNCT00091442 · 2004-09-01 · 1 site observation
COMPLETED
Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast CancerNCT00073528 · 2003-12-09 · 1 site observation
COMPLETED
Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In SituNCT00072462 · 2003-09-01 · 1 site observation
COMPLETED
Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast CancerNCT00078832 · 2003-09-01 · 1 site observation
COMPLETED
Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast CancerNCT00050141 · 2002-09-01 · 1 site observation
COMPLETED
A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast CancerNCT00241449 · 1998-11-01 · 1 site observation
COMPLETED
Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast CancerNCT00038467 · 1998-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.